Reports Q2 revenue $1.7M vs $2.19M last year. “While we faced a temporary headwind this quarter due to a vendor issue, our response demonstrated the strength of our operational discipline and our commitment to patients,” said John Erb, Chairman of the Board and CEO of Nuwellis (NUWE). “We’re entering the second half of the year with clear priorities, a sharpened focus on our core markets, and the confidence that we’re executing on the right strategy to drive long-term growth.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUWE:
- NUWE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Nuwellis to exit international operations to accelerate U.S. revenue growth
- Nuwellis postpones Q2 earnings release, conference call
- Nuwellis announces first successful outpatient application of Aquadex Smartflow
- Nuwellis Approves Stock Proposals at Special Meeting